EcoDrugPlus

Solute Carrier Family 6 Member 1

Ensembl ID : ENSOKIG00005000721
Gene Symbol: SLC6A1
3 Cross references
200 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSOKIG00005028618
Gene Symbol: SLC6A2
3 Cross references
197 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSOKIG00005003663
Gene Symbol: SLC6A2
3 Cross references
193 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSOKIG00005016469
Gene Symbol: SLC6A3
1 Cross references
160 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSOKIG00005015141
Gene Symbol: SLC6A3
1 Cross references
158 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSOKIG00005030633
Gene Symbol: SLC6A4A
1 Cross references
194 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOKIG00005028753
Gene Symbol: SLC9A3
3 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOKIG00005017580
Gene Symbol: SLC9A3
3 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOKIG00005018521
Gene Symbol: SLC9A3
1 Cross references
222 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOKIG00005008212
Gene Symbol: SSTR1
3 Cross references
152 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOKIG00005012773
Gene Symbol: SSTR1
3 Cross references
151 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOKIG00005035516
Gene Symbol: SSTR2
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).